F-42 OptiB Italian multicenter prospective study on tenofovir in suboptimal responders to ADV or ADV/LAM treatment: 96 weeks results on efficacy and tolerance
Titel:
F-42 OptiB Italian multicenter prospective study on tenofovir in suboptimal responders to ADV or ADV/LAM treatment: 96 weeks results on efficacy and tolerance
Auteur:
Levrero, M. Cimino, L. Lampertico, P. Vigano, M. Gaeta, G.B. Brancaccio, G. Sagnelli, E. Messina, V. Raimondo, G. Marzano, A. Fagiuoli, S. Niro, G. Santantonio, T. Puoti, M. Di Marco, V. Mazzella, G. Di Costanzo, G.G. Angelico, M. Pierconti, S. Sava', C. Subic, M.